Global Hyperbaric Oxygen Therapy (HBOT) Market, By Product Type (Monoplace HBOT, Multiplace HBOT and Topical HBOT devices), Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism and Others), End-Use (Hospitals and Clinics, Ambulatory Surgery Centres and Others) - Industry Trends and Forecast to 2030.
Hyperbaric Oxygen Therapy (HBOT) Market Analysis and Size
According to the Centers for Disease Control and Prevention (CDC), over 30 million Americans had diabetes in 2017. Increased blood oxygen levels brought on by HBOT aid in the development of vessels, which is essential for people with diabetes. As a result, the market for hyperbaric oxygen therapy is growing. Due to the significant increase in the frequency of wounds and injuries brought on by the growing popularity of adventure sports, physiotherapists now advise HBOT for serious wounds. HBOT is used to treat various medical conditions. The increased oxygen levels in the body can enhance the healing of certain wounds and promote the repair of damaged tissues. It's commonly employed for conditions such as non-healing wounds, diabetic foot ulcers, decompression sickness (commonly seen in scuba divers), carbon monoxide poisoning, and certain types of infections will eventually result in the growth of the global hyperbaric oxygen therapy (HBOT) market.
Data Bridge Market Research analyses that the global hyperbaric oxygen therapy (HBOT) market which was USD 3.71 billion in 2022, is expected to reach USD 7.61 billion by 2030, and is expected to undergo a CAGR of 9.40% during the forecast period of 2023 to 2030. “Wound healing” dominates the application segment of the global hyperbaric oxygen therapy (HBOT) market owing to it superiority in healing the wounds. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Hyperbaric Oxygen Therapy (HBOT) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Monoplace HBOT, Multiplace HBOT and Topical HBOT devices), Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism and Others), End-Use (Hospitals and Clinics, Ambulatory Surgery Centres and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Perry Baromedical (U.S.), Sechrist Industries, Inc. (U.S.), Tekna Hyperbaric (India), Pan America Hyperbarics, Inc. (U.S.), HAUX-LIFE-SUPPORT (Germany), PCCI (France), Hipertech Electronics Inc. (U.S.), Sosgroup (U.S.), HEARMEC (France), OxyHealth (U.S.), Environmental Tectonics Corporation (U.S.), IHC Merwede Holding B.V. (Netherlands), Advanced Biomedical Engineering (Japan), Airox Technologies Private Limited (India), Biovision Healthcare (India), Richmond Hyperbaric Health Center (Canada), and Universe Surgical Equipment Co. (India)
|
|
Market Opportunities
|
|
Market Definition
Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that involves breathing pure oxygen in a pressurized environment. Typically, this is done in a special room or chamber. The pressure in the chamber is increased to a level higher than atmospheric pressure, allowing the lungs to gather more oxygen than would be possible breathing pure oxygen at normal air pressure. In addition, there is ongoing research exploring its potential benefits for conditions such as traumatic brain injuries and neurological disorders.
Global Hyperbaric Oxygen Therapy (HBOT) Market Dynamics
Drivers
- Expanding Indications of hyperbaric oxygen therapy
Ongoing research continues to unveil new therapeutic possibilities for HBOT, extending beyond its traditional applications. For instance, studies exploring its efficacy in traumatic brain injuries, chronic inflammatory conditions, and even certain aspects of regenerative medicine are broadening the range of conditions for which HBOT may be considered. As these indications expand, healthcare providers are more likely to incorporate HBOT into their treatment strategies, further driving its growth.
- Increasing Awareness among People
The dissemination of accurate information about HBOT through educational initiatives, medical conferences, and media coverage contributes to heightened awareness among both healthcare professionals and the public. Understanding the diverse applications and benefits of HBOT fosters informed decision-making, encouraging more individuals to explore it as a viable therapeutic option. Increased awareness also helps mitigate misconceptions surrounding the therapy, paving the way for its broader acceptance within the medical community and among potential recipients of the treatment.
Opportunities
- Rising of the Technological Advancements
Continued progress in hyperbaric chamber technology may result in more portable and cost-effective devices, increasing accessibility. Advanced features, such as improved oxygen delivery systems and enhanced monitoring capabilities, could make the therapy more efficient and safer for a wider range of medical applications.
- Integration with Other Therapies
The growth of HBOT could foster collaborative approaches in healthcare, where it becomes an integrated component of treatment plans. Combining hyperbaric oxygen therapy with other modalities, such as pharmaceuticals or advanced medical devices, may offer synergistic benefits, leading to more comprehensive and personalized treatment strategies for patients.
Restraints/Challenges
- Limited Evidence for Some Conditions
While HBOT has demonstrated efficacy for certain conditions such as chronic wounds and decompression sickness, the scientific evidence supporting its use for other ailments, such as neurological disorders or chronic inflammatory conditions, may be less robust. Insufficient research in these areas can create hesitancy among healthcare providers and limit its broader adoption.
- Lack of Standardized of Protocols
The absence of standardized treatment protocols for various medical conditions treated with HBOT poses a challenge. Establishing universally accepted guidelines for dosages, session durations, and specific applications is essential for ensuring consistency in therapeutic outcomes and fostering broader acceptance within the medical community.
This global hyperbaric oxygen therapy (HBOT) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global hyperbaric oxygen therapy (HBOT) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In February 2020, Environmental Tectonics Corporation Biomedical Systems' hyperbaric segment was purchased by Perry Baromedical Corporation. Perry Baromedical Corporation expanded and penetrated markets in the Asia-Pacific region thanks to the acquisition. In addition, the acquisition improved the installed base both domestically and internationally
- In November 2019, At the MEDICA trade fair in Germany, AHA Hyperbarics GmbH unveiled the AHA Flex V2 hyperbaric system. The AHA Flex V2 hyperbaric system is used to treat diabetic foot ulcers, crush injuries, and cerebrovascular insult (CVI). This grid-powered device, which consists of two bags, operates on a 2.0 bar
Global Hyperbaric Oxygen Therapy (HBOT) Market Scope
The global hyperbaric oxygen therapy (HBOT) market is segmented on the basis of product type, application, and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Monoplace HBOT
- Multiplace HBOT
- Topical HBOT devices
Application
- Wound Healing
- Decompression Sickness
- Infection Treatment
- Gas Embolism
- Others
End Use
- Hospitals and Clinics
- Ambulatory Surgery Centres
- Others
Global Hyperbaric Oxygen Therapy (HBOT) Market Regional Analysis/Insights
The global hyperbaric oxygen therapy (HBOT) market is analysed and market size insights and trends are provided by product type, application and end use as referenced above.
The countries covered in the global hyperbaric oxygen therapy (HBOT) market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global hyperbaric oxygen therapy (HBOT) market with a major share of the market due to the presence of competitors with technological advancements is the major reason for the continuous growth.
Asia-Pacific looks promising and is expected to be the fastest growing region in and also, to exhibit the highest CAGR in the global hyperbaric oxygen therapy (HBOT) market during the forecast period of 2023 to 2030, due to the growing number of patients with acute and chronic diseases and other health problems such as diabetes, asthma, and others.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global hyperbaric oxygen therapy (HBOT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global hyperbaric oxygen therapy (HBOT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global hyperbaric oxygen therapy (HBOT) market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Hyperbaric Oxygen Therapy (HBOT) Market Share Analysis
The global hyperbaric oxygen therapy (HBOT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global hyperbaric oxygen therapy (HBOT) market.
Some of the major players operating in the global hyperbaric oxygen therapy (HBOT) market are:
- Perry Baromedical (U.S.)
- Sechrist Industries, Inc. (U.S.)
- Tekna Hyperbaric (India)
- Pan America Hyperbarics, Inc. (U.S.)
- HAUX-LIFE-SUPPORT (Germany)
- PCCI (France)
- Hipertech Electronics Inc. (U.S.)
- Sosgroup (U.S.)
- HEARMEC (France)
- OxyHealth (U.S.)
- Environmental Tectonics Corporation (U.S.)
- IHC Merwede Holding B.V. (Netherlands)
- Advanced Biomedical Engineering (Japan)
- Airox Technologies Private Limited (India)
- Biovision Healthcare (India)
- Richmond Hyperbaric Health Center (Canada)
- Universe Surgical Equipment Co. (India)
SKU-